C. DANIEL MYERS

Profile

First Name

: C.

Middle Name

: DANIEL

Last Name

: MYERS

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
ALIMERA SCIENCES INC
PHILIP ASHMAN, GLEN BRADLEY, MARK BROOKS, SUSAN CABALLA, RICHARD EISWIRTH, RICHARD S. EISWIRTH, RICHARD S. EISWIRTH, JR., KENNETH GREEN, BRIAN HALAK, BRIAN K. HALAK, DAVID HOLLAND, ANDERS HOVE, J. PHILIP JONES, MICHAEL KASETA, GARHENG KONG, JAMES R. LARGENT, ADAM MORGAN, CHARLES DANIEL MYERS, DANIEL MYERS, ERIN PARSONS, PETER J. PIZZO, PETER J. PIZZO III, CALVIN ROBERTS, CALVIN W. ROBERTS, ROGER SAWHENY, RUSSELL SKIBSTED, JOHN SNISARENKO, MARY T. SZELA, PHIL TRACY, PHILIP TRACY, BRYCE YOUNGREN
DIRECTOR
KALA PHARMACEUTICALS, INC.
TODD BAZEMORE, CHAIM BERGER, KEVIN BITTERMAN, MARK S. BLUMENKRANZ, KIM BRAZZELL, HONGMING CHEN, YONATAN COLMAN, PETER COUROSSI, MARJAN FARID, ANDREA FRANZ, BERNARD GILLY, GREG GRUNBERG, GREGORY GRUNBERG, JUSTIN HANES, MARK IWICKI, DARIUS KHARABI, ANDREW I. KOVEN, ANDREW L. KOVEN, ROBERT LANGER, DAVID LAZAR, CHARLES MCDERMOTT, AVI MINKOWITZ, ROBERT PAULL, GREGORY D. PERRY, GUILLAUME PFEFER, KEVIN POJASEK, HILLEL POSEN, BRENDAN PURDY, MARY REUMUTH, HOWARD B. ROSEN, RAJEEV SHAH, ROBERT TEPPER, ERIC L. TRACHTENBERG, KAREN WAGNER, CHEN YU
DIRECTOR
KALA BIO, INC.
TODD BAZEMORE, CHAIM BERGER, KEVIN BITTERMAN, MARK S. BLUMENKRANZ, KIM BRAZZELL, HONGMING CHEN, YONATAN COLMAN, PETER COUROSSI, MARJAN FARID, ANDREA FRANZ, BERNARD GILLY, GREG GRUNBERG, GREGORY GRUNBERG, JUSTIN HANES, MARK IWICKI, DARIUS KHARABI, ANDREW I. KOVEN, ANDREW L. KOVEN, ROBERT LANGER, DAVID LAZAR, CHARLES MCDERMOTT, AVI MINKOWITZ, ROBERT PAULL, GREGORY D. PERRY, GUILLAUME PFEFER, KEVIN POJASEK, HILLEL POSEN, BRENDAN PURDY, MARY REUMUTH, HOWARD B. ROSEN, RAJEEV SHAH, ROBERT TEPPER, ERIC L. TRACHTENBERG, KAREN WAGNER, CHEN YU
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-12-31 
2024-06-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2021-11-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-15 
2021-04-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2021-04-14 
2014-02-18
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-01-31 
2012-10-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-02